Suppr超能文献

人黑色素瘤异种移植瘤分次放疗期间的再增殖

Repopulation between radiation fractions in human melanoma xenografts.

作者信息

Rofstad E K

机构信息

Institute for Cancer Research, Norwegian Radium Hospital, Oslo.

出版信息

Int J Radiat Oncol Biol Phys. 1992;23(1):63-8. doi: 10.1016/0360-3016(92)90544-r.

Abstract

Rate of tumor repopulation between radiation fractions was studied using two human melanoma xenograft lines (E.F. and V.N.). Tumors were given five radiation fractions under hypoxic conditions in vivo and clonogenic cells survival was measured in vitro after the last radiation fraction. Dose-response curves were established for interfraction times of 12, 24, 36, and 48 hr by varying dose per fraction from 4.2 to 11.2 Gy. Assuming an oxygen enhancement ratio of 2.8, these doses corresponded to doses of 1.5 to 4.0 Gy under aerobic conditions, that is, clinically relevant doses per fraction were used. The dose-response curves were nearly parallel and were shifted to the right with increasing interfraction time, demonstrating significant repopulation between the radiation fractions. Iso-effect analyses showed that additional radiation doses of 2.0 +/- 0.6 Gy/day (E.F.) and 2.2 +/- 0.6 Gy/day (V.N.), corresponding to doses of 0.7 +/- 0.2 Gy/day (E.F.) and 0.8 +/- 0.2 Gy/day under aerobic conditions, would be required to compensate for the repopulation. These doses were equivalent to the surviving clonogenic cells showing doubling times of 40-50 hr (E.F.) and 30-40 hr (V.N.) during the treatment period. The radioresponsiveness of the two melanoma xenograft lines was also measured. Tumors in air-breathing mice were given from 5 to 15 daily fractions of 2.0 Gy and cell survival curves were established in vitro. Theoretical survival curves, calculated from SF2 in vitro and rate of repopulation during fractionated irradiation in vivo, agreed fairly well with the measured survival curves. This suggested that the radioresponsiveness of the melanoma xenograft lines was governed by two main parameters: (a) cellular radiation sensitivity and repair capacity and (b) rate of repopulation between radiation fractions.

摘要

利用两个人类黑色素瘤异种移植系(E.F.和V.N.)研究了分次放疗期间肿瘤再增殖率。在体内低氧条件下对肿瘤进行5次分次放疗,并在最后一次放疗后体外测量克隆形成细胞存活率。通过将每次分次剂量从4.2 Gy变化到11.2 Gy,建立了分次间隔时间为12、24、36和48小时的剂量反应曲线。假设氧增强比为2.8,这些剂量相当于有氧条件下1.5至4.0 Gy的剂量,即使用了临床相关的分次剂量。剂量反应曲线几乎平行,且随着分次间隔时间的增加向右移动,表明分次放疗期间存在显著的再增殖。等效效应分析表明,需要额外的放疗剂量2.0±0.6 Gy/天(E.F.)和2.2±0.6 Gy/天(V.N.),相当于有氧条件下0.7±0.2 Gy/天(E.F.)和0.8±0.2 Gy/天,以补偿再增殖。这些剂量相当于在治疗期间克隆形成存活细胞的倍增时间为40 - 50小时(E.F.)和30 - 40小时(V.N.)。还测量了两个人类黑色素瘤异种移植系的放射敏感性。给呼吸空气的小鼠体内肿瘤每天给予5至15次2.0 Gy的分次放疗,并在体外建立细胞存活曲线。根据体外SF2和体内分次照射期间的再增殖率计算的理论存活曲线与测量的存活曲线相当吻合。这表明人类黑色素瘤异种移植系的放射敏感性受两个主要参数控制:(a)细胞放射敏感性和修复能力,以及(b)分次放疗期间的再增殖率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验